VJHemOnc is committed to improving our service to you

EHA 2020 | Impact of COVID-19 on treatment of B-cell malignancies

VJHemOnc is committed to improving our service to you

Arnon Kater

Arnon Kater, MD, PhD, of the University of Amsterdam, Amsterdam, Netherlands, explores the impact of COVID-19 on the treatment of B-cell malignancies. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter